We are live on
!
Find out more
TG
TLP Group Portfolio holdings
AUM
$6.61M
1-Year Est. Return
12.46%
This Fund
S&P 500
This Quarter
Est. Return
+3.51%
1 Year Est. Return
-12.46%
3 Year Est. Return
+42.65%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$65.8M
AUM Growth
-$80M
(-55%)
Cap. Flow
-$131M
Cap. Flow
% of AUM
-199.18%
Top 10 Holdings %
Top 10 Hldgs %
49.58%
Holding
538
New
154
Increased
37
Reduced
174
Closed
157
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 2000 ETF
IWM
|
+$7.91M |
| 2 |
iShares Biotechnology ETF
IBB
|
+$888K |
| 3 |
Morgan Stanley
MS
|
+$644K |
| 4 |
Eli Lilly
LLY
|
+$522K |
| 5 |
Franklin Resources
BEN
|
+$368K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AIMT
Aimmune Therapeutics
AIMT
|
+$18.5M |
| 2 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$8.78M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$8.64M |
| 4 |
Merck
MRK
|
+$637K |
| 5 |
CNX Resources
CNX
|
+$517K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 16.05% |
| 2 | Financials | 13.36% |
| 3 | Industrials | 5.98% |
| 4 | Real Estate | 5.72% |
| 5 | Consumer Discretionary | 5.1% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
Emerson Electric
EMR
$81.2B
| $61K | 0.09% |
883
-2,080
| -70% | -$146K |
|
152
PUT
Invesco QQQ Trust
QQQ
$460B
| $61K | 0.09% |
19,500
| – | – |
|
153
Under Armour Class C
UA
$2.81B
| $61K | 0.09% |
+2,894
| New | +$51.4K |
|
154
Aflac
AFL
$63.3B
| $59K | 0.09% |
1,369
-3,808
| -74% | -$171K |
|
155
Dick's Sporting Goods
DKS
$18.3B
| $59K | 0.09% |
1,663
-4,434
| -73% | -$150K |
|
|
ECHO
156
EchoStar
ECHO
$26.5B
| $59K | 0.09% |
1,647
-3,962
| -71% | -$162K |
|
157
Fastenal
FAST
$53B
| $58K | 0.09% |
+4,792
| New | +$62K |
|
158
PUT
Gilead Sciences
GILD
$162B
| $58K | 0.09% |
20,000
| – | – |
|
159
Stanley Black & Decker
SWK
$13.6B
| $56K | 0.09% |
421
-1,064
| -72% | -$153K |
|
160
Navient
NAVI
$793M
| $54K | 0.08% |
4,143
-440
| -10% | -$5.99K |
|
161
Choice Hotels
CHH
$4.91B
| $52K | 0.08% |
690
-4,611
| -87% | -$370K |
|
162
Markel Group
MKL
$24.5B
| $52K | 0.08% |
+48
| New | +$54.2K |
|
163
W.P. Carey
WPC
$16.7B
| $51K | 0.08% |
+778
| New | +$49.3K |
|
164
ExxonMobil
XOM
$650B
| $51K | 0.08% |
621
-3,628
| -85% | -$289K |
|
165
Moody's
MCO
$82.5B
| $50K | 0.08% |
291
-2,536
| -90% | -$429K |
|
166
Waters Corp
WAT
$37.5B
| $50K | 0.08% |
258
-1,879
| -88% | -$370K |
|
167
Illinois Tool Works
ITW
$79.7B
| $48K | 0.07% |
350
-2,386
| -87% | -$353K |
|
168
Lockheed Martin
LMT
$131B
| $48K | 0.07% |
+164
| New | +$52.9K |
|
169
Bruker
BRKR
$9.46B
| $47K | 0.07% |
1,624
-4,718
| -74% | -$143K |
|
|
170
PUT
Merck
MRK
$322B
| $47K | 0.07% |
71,369
-144,624
| -67% | -$8.16M |
|
171
Procter & Gamble
PG
$342B
| $46K | 0.07% |
595
-4,873
| -89% | -$367K |
|
172
Macy's
M
$6.14B
| $45K | 0.07% |
+1,190
| New | +$39.9K |
|
173
Chubb
CB
$137B
| $44K | 0.07% |
349
-170
| -33% | -$22.6K |
|
174
IBM
IBM
$194B
| $44K | 0.07% |
327
-64
| -16% | -$8.93K |
|
|
SAFE
175
Safehold
SAFE
$1.15B
| $44K | 0.07% |
847
-3,441
| -80% | -$177K |
|
Similar funds
LAM
SPCP
GZ
RGNCM
FCM
DCM
DAL
SAM
TLP Group's Q2 2018 Portfolio in Review
As of Q2 2018, TLP Group held 538 positions worth $65.8M, down 55% from $146M the previous quarter. Its ten largest holdings account for 50% of the portfolio.
TLP Group withdrew a net $131M in Q2 2018, closing 157 positions and reducing 174 holdings. Its most notable exit was Aimmune Therapeutics, an estimated $18.5M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 11% a quarter earlier, followed by Financials and Industrials.
Against the trend, TLP Group opened a new position in Franklin Resources worth $352K.
- TLP Group's largest Q2 2018 buy was Franklin Resources: 10,992 shares worth $352K.
- TLP Group added most to iShares Russell 2000 ETF in Q2 2018, an estimated $7.91M increase.
- TLP Group's biggest Q2 2018 reduction was State Street Health Care Select Sector SPDR ETF, cutting an estimated $8.78M.
- TLP Group fully exited Aimmune Therapeutics in Q2 2018, selling an estimated $18.5M.
- TLP Group's ten largest holdings make up 50% of its $65.8M portfolio in Q2 2018.
- TLP Group opened 154 new positions and closed 157 in Q2 2018.
- TLP Group's portfolio value fell 55% quarter-over-quarter to $65.8M.
Based on TLP Group's 13F filing for Q2 2018, filed 14 Aug 2018.